Intervention strategies for microbial therapeutics in cancer immunotherapy

Immunotherapies have drastically improved clinical outcomes in a wide range of malignancies. Nevertheless, patient responses remain highly variable, and reliable biomarkers that predict responses accurately are not yet fully understood. Compelling evidence from preclinical studies and observational...

Descripción completa

Detalles Bibliográficos
Autores principales: Gopalakrishnan, V., Weiner, B., Ford, C.B., Sellman, B.R., Hammond, S.A., Freeman, D.J., Dennis, P., Soria, J-C., Wortman, J.R., Henn, M.R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216385/
https://www.ncbi.nlm.nih.gov/pubmed/35757236
http://dx.doi.org/10.1016/j.iotech.2020.05.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216385/
https://www.ncbi.nlm.nih.gov/pubmed/35757236
http://dx.doi.org/10.1016/j.iotech.2020.05.001

Ejemplares similares